BioSpace News Archive

Press Releases

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time

December 4, 2024
·
1 min read
Press Releases

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

December 4, 2024
·
6 min read
Press Releases

Sonnet BioTherapeutics Announces Publication Detailing the Discovery and Development of SON-1010, an Albumin-Binding IL-12 Fusion Protein, Demonstrating Its Mechanism of Action

December 4, 2024
·
6 min read
Press Releases

EyePoint Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU™ for the Treatment of Wet Age-Related Macular Degeneration

December 4, 2024
·
11 min read
Press Releases

Arrakis Therapeutics Unveils Data for its Lead, Rationally Designed, RNA-Targeted Small Molecule (rSM) Drug Program Demonstrating Disease-Modifying Binding to RNA to Treat Myotonic Dystrophy

December 4, 2024
·
5 min read
Press Releases

Atea Pharmaceuticals Announces Positive Results from Phase 2 Study of Bemnifosbuvir and Ruzasvir Regimen for Treatment of Hepatitis C Virus (HCV)

December 4, 2024
·
8 min read
Press Releases

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers

December 4, 2024
·
3 min read
Press Releases

VitriVax Awarded $3.6M Grant for Polio Vaccine Development

December 4, 2024
·
1 min read
Press Releases

Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome

December 4, 2024
·
8 min read
Press Releases

Relmada Therapeutics Reports That Data Monitoring Committee (DMC) Assessment Indicates That the Phase 3 Reliance II Trial is Futile at its Interim Analysis and is Unlikely to Meet the Primary Efficacy Endpoint with Statistical Significance

December 4, 2024
·
4 min read